Urinary Bag Market Segment Overview, Regional Analysis and Forecast to 2031

The global urinary bag market will rise at a CAGR of 4.4% CAGR between 2021 and 2031.

Between 2016 and 2020, the global urinary bag market grew at a moderate CAGR of more than 3.5%. According to a World Health Organization (WHO) report, the prevalence of urine incontinence in population-based studies ranged from 9.9% to 36.1% (2-4), with older women being twice as likely as older men. Urinary bags are frequently employed in the treatment of urine incontinence, ulcerative colitis, retention, and spinal cord injury.

According to the Continence Foundation of Australia, around 38% of women and 13% of men in Australia were affected by urinary incontinence in 2019, accounting for more than one in every three Australians. According to the survey, the illness is more common in women (61%), persons with arthritis (57%), diabetes (46%), impairments (47%), mental health disorders (53%), and males with prostate problems (54%).

The United States controls more than 90% of the North American market. The United States' healthcare system is well-known for its infrastructure and spending. Applications in cancer care facilities and hospitals are determined by rules and insurance policies, which promotes the country's market growth.

According to the Urology Care Foundation, 40 percent of women and 30 percent of men in the United States experienced overactive bladder symptoms in 2019.

Germany is estimated to expand at a CAGR of 5% through 2031, reaching a valuation of US$ 270 Million.

Germany is a world leader in pharmaceutical and healthcare product manufacturing. Manufacturers in the country have built a competitive environment by manufacturing products and utilising cutting-edge research to increase functioning.

Browse More@ https://www.futuremarketinsights.com/reports/urinary-bag-market

Some of the leading companies operating in the market are:

  • Medline Industries, Inc.
  • Cardinal Health, Inc.
  • Hollister Incorporated
  • Teleflex Incorporated
  • Cook Medical
  • Moore Medical LLc
  • Mckesson Medical-Surgical Inc.
  • Arcus Medical LLc
  • Urocare
  • Covidien
  • Others

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more